{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:44Z","timestamp":1791323684976,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.seizure.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:31:39Z","timestamp":1786033899000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intravenous lacosamide for pediatric status epilepticus and seizure clusters: A single-center observational study"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3323-9336","authenticated-orcid":false,"given":"Nathalia Elena","family":"Penagos Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0097-9890","authenticated-orcid":false,"given":"David","family":"Montoya Ossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-4951","authenticated-orcid":false,"given":"Oscar Mauricio","family":"Espitia Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-645X","authenticated-orcid":false,"given":"Juan David","family":"Farf\u00e1n-Albarrac\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.seizure.2026.08.003_bib0001","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","article-title":"Global, regional, and national burden of epilepsy, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"10","author":"Feigin","year":"2025","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.seizure.2026.08.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70139","article-title":"Global, regional, and national burden of epilepsy in children and adolescents, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"56","author":"Kim","year":"2026","journal-title":"Eur J Clin Investig"},{"issue":"6","key":"10.1016\/j.seizure.2026.08.003_bib0003","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2015.0188","article-title":"Trends in status epilepticus-related hospitalizations and mortality: redefined in US practice over time","volume":"72","author":"Betjemann","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2026.08.003_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2018.08.021","article-title":"The burden of pediatric status epilepticus: epidemiology, morbidity, mortality, and costs","volume":"68","author":"Gurcharran","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.08.003_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2018.01.014","article-title":"Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: a systematic review","volume":"56","author":"Ortiz de la Rosa","year":"2018","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2026.08.003_bib0006","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.08.003_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/nyas.12513","article-title":"Advances in epilepsy treatment: lacosamide pharmacokinetic profile","volume":"1329","author":"Cawello","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.seizure.2026.08.003_bib0008","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/B978-0-7020-4086-3.00027-8","article-title":"Use of antiepileptic drugs in hepatic and renal disease","volume":"119","author":"Asconap\u00e9","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2026.08.003_bib0009","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jpc.14156","article-title":"Lacosamide in children with drug-resistant epilepsy","volume":"55","author":"R\u00fcegger","year":"2019","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.seizure.2026.08.003_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/ane.12809","article-title":"Outcome of cancer-related seizures in patients treated with lacosamide","volume":"137","author":"Toledo","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.seizure.2026.08.003_bib0011","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1528-1167.2009.02463.x","article-title":"Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures","volume":"51","author":"Krauss","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2026.08.003_bib0012","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"H\u00f6fler","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2026.08.003_bib0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nurt.2006.10.002","article-title":"Lacosamide","volume":"4","author":"Doty","year":"2007","journal-title":"Neurother: J Am Soc Exp NeuroTher"},{"issue":"2","key":"10.1016\/j.seizure.2026.08.003_bib0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejpn.2015.12.013","article-title":"Clinical experience of intravenous lacosamide in infants and young children","volume":"20","author":"Arkilo","year":"2016","journal-title":"Eur J Paediatr Neurol: EJPN: Off J Eur Paediatr Neurol Soc"},{"issue":"3","key":"10.1016\/j.seizure.2026.08.003_bib0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/acn3.52004","article-title":"Efficacy and tolerability of adjunctive lacosamide in patients aged <4 years with focal seizures","volume":"11","author":"Makedonska","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2026.08.003_bib0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.seizure.2026.08.003_bib0017","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2026.08.003_bib0018","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2011.12.008","article-title":"Intravenous lacosamide in refractory nonconvulsive status epilepticus","volume":"21","author":"Mnatsakanyan","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.08.003_bib0019","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yebeh.2014.05.015","article-title":"Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study","volume":"36","author":"Garc\u00e9s","year":"2014","journal-title":"Epilepsy Behav: E&B"},{"issue":"10","key":"10.1016\/j.seizure.2026.08.003_bib0020","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1111\/j.1528-1167.2011.03204.x","article-title":"Intravenous lacosamide in status epilepticus and seizure clusters","volume":"52","author":"H\u00f6fler","year":"2011","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.08.003_bib0021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0306-4522(03)00168-4","article-title":"Molecular and functional changes in voltage-dependent Na (+) channels following pilocarpine-induced status epilepticus in rat dentate granule cells","volume":"119","author":"Ellerkmann","year":"2003","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.seizure.2026.08.003_bib0022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","article-title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","volume":"9","author":"Mantegazza","year":"2010","journal-title":"Lancet, Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2026.08.003_bib0023","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40261-015-0295-5","article-title":"Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus","volume":"35","author":"Moreno Morales","year":"2015","journal-title":"Clin Drug Investig"},{"issue":"10231","key":"10.1016\/j.seizure.2026.08.003_bib0024","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet (Lond Engl)"},{"issue":"9","key":"10.1016\/j.seizure.2026.08.003_bib0025","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/epi.17676","article-title":"Safety of intravenous lacosamide in hospitalized children and neonates","volume":"64","author":"Fong","year":"2023","journal-title":"Epilepsia"},{"issue":"3\u20134","key":"10.1016\/j.seizure.2026.08.003_bib0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/08830738231164835","article-title":"Tolerability and safety of lacosamide in neonatal population","volume":"38","author":"Bamgbose","year":"2023","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2026.08.003_bib0027","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pediatrneurol.2024.05.019","article-title":"Clinical experience with lacosamide as an adjunct treatment for neonatal seizures: a retrospective single-center study","volume":"157","author":"Chourasia","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2026.08.003_bib0028","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpn.2014.04.013","article-title":"Lacosamide in children with refractory status epilepticus. A multicenter Italian experience","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol: EJPN: Off J Eur Paediatr Neurol Soc"},{"key":"10.1016\/j.seizure.2026.08.003_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2024.03.007","article-title":"Retrospective multicenter cohort study on safety and electroencephalographic response to lacosamide for neonatal seizures","volume":"155","author":"Kaur","year":"2024","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2026.08.003_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2024.05.003","article-title":"Intravenous lacosamide therapy for pediatric patients with seizure clusters","volume":"157","author":"Matsuura","year":"2024","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2026.08.003_bib0031","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pediatrneurol.2016.03.021","article-title":"Intravenous lacosamide in pediatric status epilepticus: an open-label efficacy and safety study","volume":"61","author":"Poddar","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2026.08.003_bib0032","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pediatrneurol.2023.09.021","article-title":"Lacosamide for the treatment of seizures in neonates and infants: a retrospective assessment of efficacy and tolerability","volume":"149","author":"Shoaib","year":"2023","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2026.08.003_bib0033","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status Epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:49:39Z","timestamp":1791323379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126002311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S1059131126002311"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.08.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous lacosamide for pediatric status epilepticus and seizure clusters: A single-center observational study","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}